Growth Retardation In Children With Special Pathological Conditions Or Disease

Evolution Of Growth Rate In Children Suffering From A Disease Associated With Growth Retardation and Treated By Genotonorm. A Pilot Study.

To show an increase in annual growth rate 3 years after Visit 2. Annual growth rate in standard deviation (SD) after 3 years will be compared to growth rate before the start of GH treatment.

Inclusion Criteria:

• Bone age < 13 years for a boy and < 11 years for a girl
• Naive child: Measured Height < -2.5 SD for CA
• Child currently treated by GH

Exclusion Criteria:

• Idiopathic short stature
• Syndrome known to be associated with an increased risk of cancer e.g. family history of adenomatous polyposis